<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>300</height>
  <width>600</width>
  <title>Repigment, Reframe, Restore: JAK Inhibition A New Era for Vitiligo 🎯</title>
  <description>🎨 Repigment, Reframe, Restore: A New Era for Vitiligo Vitiligo is far more than a cosmetic condition. In two phase 3 Viti-Up trials, oral upadacitinib 15 mg significantly improved facial and total-body repigmentation at 48 weeks. 💊 But here is the deeper lesson: better pigmentation ≠ complete patient benefit. Only 13–15% reported their vitiligo as “a lot less” or “no longer” noticeable. 👁️ The future of vitiligo care must measure not only pigment, but also dignity, mental health, long-term safety and access. 🧠❤️ #Vitiligo #Dermatology #JAKInhibitors #MedicalPodcasts </description>
  <author_name>Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!</author_name>
  <author_url>http://www.MasterMedFacts.com</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/42482715/height/300/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="300" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/205224575</thumbnail_url>
</oembed>
